Article

A cost analysis of a cancer genetic service model in the UK

2015-09-18

Abstract excerpt

<h4>Background</h4> Technological advances in DNA sequencing have made gene testing fast and more affordable. Evidence of cost-effectiveness of genetic service models is essential for successful translation, but remain sparse in the literature. In particular there is a lack of cost data related to genetic services. <h4>Methods</h4> A detailed micro-costing of 28 pathways relating to breast and/or ovarian cancer...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 332e06a1-0f89-5fec-aa31-1e8dbb517dd0
DOI: 10.1101/027185

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

A cost analysis of a cancer genetic service model in the UKDOI 10.1101/027185Read

Cancer genetics services: a systematic review of the economic evidence and issues.Semantic proximity Read

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patientsSemantic proximity Read

Health economics and genetic service development: a familial cancer genetic example.Semantic proximity Read

Implementing rapid, robust, cost-effective, patient-centred, routine genetic testing in ovarian cancer patients.Semantic proximity Read

Uptake of risk-reducing surgery in BRCA gene carriers in Wales, UK.Semantic proximity Read

A Cost-Effectiveness Evaluation of Germline BRCA1 and BRCA2 Testing in UK Women with Ovarian Cancer.Semantic proximity Read

Steering a course around the genetic iceberg.Semantic proximity Read

Micro-costing Diagnostics in Oncology: From Single-Gene Testing to Whole Genome SequencingSemantic proximity Read

Economic evaluation of extended panel analysis in cancer patients with historical NHS diagnostic germline genetic testing - A modeling study based on real-world data.Semantic proximity Read

Developing national guidance on genetic testing for breast cancer predisposition: the role of economic evidence?Semantic proximity Read

A model protocol evaluating the introduction of genetic assessment for women with a family history of breast cancer.Semantic proximity Read

A discrete event simulation to evaluate the cost effectiveness of germline <i>BRCA1</i> and <i>BRCA2</i> testing in UK women with ovarian cancerSemantic proximity Read